User:EugeneBuff: Difference between revisions
Jump to navigation
Jump to search
imported>Larry Sanger No edit summary |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{AccountNotLive}} | |||
Summary: | Summary: | ||
Line 19: | Line 18: | ||
• Genetics of development | • Genetics of development | ||
• Signal Transduction | • Signal Transduction | ||
[[Category:Inactive CZ Editors|EugeneBuff]] | |||
[[Category:Inactive Business Editors|EugeneBuff]] | |||
[[Category:Inactive Health Sciences Editors|EugeneBuff]] |
Latest revision as of 02:51, 22 November 2023
The account of this former contributor was not re-activated after the server upgrade of March 2022.
Summary:
MD/PhD with over fifteen years of combined scientific, consulting, technology transfer and managerial experience. See more at http://www.linkedin.com/in/eugenebuff
Specialties:
• Technology Scouting and Acquisitions • Deal Making (Licensing Consulting) • Market Analysis • Technology Positioning and Marketing • IP (Intellectual Property) Management and Valuation • Open Innovation Consulting • Due Diligence
• Genetics • Genetics of development • Signal Transduction